SXPCX
Price
$47.73
Change
-$1.46 (-2.97%)
Updated
Dec 18 closing price
VFIAX
Price
$543.40
Change
-$16.50 (-2.95%)
Updated
Dec 18 closing price
Ad is loading...

SXPCX vs VFIAX

Header iconSXPCX vs VFIAX Comparison
Open Charts SXPCX vs VFIAXBanner chart's image
DWS S&P 500 Index C
Price$47.73
Change-$1.46 (-2.97%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Admiral
Price$543.40
Change-$16.50 (-2.95%)
VolumeN/A
CapitalizationN/A
SXPCX vs VFIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SXPCX vs. VFIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SXPCX is a StrongBuy and VFIAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.37T vs. SXPCX (1.43B). VFIAX pays higher dividends than SXPCX: VFIAX (1.32) vs SXPCX (0.20). SXPCX was incepted earlier than VFIAX: SXPCX (20 years) vs VFIAX (24 years). SXPCX (2.00) and VFIAX (2.00) have comparable annual turnover. SXPCX has a lower initial minimum investment than VFIAX: SXPCX (1000) vs VFIAX (3000). VFIAX annual gain was more profitable for investors over the last year : 27.64 vs. SXPCX (22.32). VFIAX return over 5 years is better than : 88.64 vs. SXPCX (49.88).
SXPCXVFIAXSXPCX / VFIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years24 years-
Gain YTD21.56627.30379%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.43B1.37T0%
Annual Yield % from dividends0.201.3215%
Returns for 1 year22.3227.6481%
Returns for 3 years14.4030.9946%
Returns for 5 years49.8888.6456%
Returns for 10 years96.59193.6650%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGNX3.340.11
+3.41%
MacroGenics
ES58.510.38
+0.65%
Eversource Energy
PSTX9.50-0.01
-0.11%
Poseida Therapeutics
SLG74.11-1.23
-1.63%
SL Green Realty Corp
BTAI0.39-0.02
-4.01%
BioXcel Therapeutics